Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Terminated 3

Sponsor Class

OTHER 3NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Prostatic Neoplasms 1Leukoplakia, Oral 1

Interventions

Cyclophosphamide 47aldesleukin 30fludarabine phosphate 26fludarabine 24Carboplatin 18Rituximab 16Interleukin-2 16Cisplatin 16Bevacizumab 162,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 16Radiotherapy 15Paclitaxel 15Magnetic Resonance Spectroscopy 14Bortezomib 14Filgrastim 13Doxorubicin 13Oxaliplatin 12Erlotinib Hydrochloride 12Trastuzumab 11Leucovorin 11Etoposide 11Biopsy 11Taxes 10Radiation 10Fluorouracil 10alvocidib 9Specimen Handling 9Sorafenib 9Docetaxel 9Dexamethasone 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × NIH × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT00571558 2014-10-09

Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia

National Cancer Institute (NCI)

Phase 1 Terminated
15 enrolled
Head & Neck

Leukoplakia, Oral

NCT00005808 2013-02-07

Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia

National Cancer Institute (NCI)

Phase 1 Terminated
54 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT00005067 2013-01-16

Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Terminated
24 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡